Abstract
Aim: To determine whether argipressin (Arg) plays a role in central neural control of cardiovascular function by acting on the lateral septal nuclei (LSN). Methods: Measuring mean arterial blood pressure (MAP) and heart rate (HR) responses followed microinjection of Arg into the LSN of rats anesthetized with urethane. Results: Arg (100, 200, and 400 ng) injected into the LSN produced a dose-dependent hypertension and tachycardia. Maximal changes of MAP were 0.9 ± 0.6, 2.3 ± 1.3, 4.0 ± 1.4 kPa, respectively; maximal changes of HR were 12 ± 27, 50 ± 33, and 89 ± 27 bpm, respectively. Pretreatment of the LSN with a vasopressin 1 type antagonist d (CH2)5Tyr (Me) Arg abolished the MAP and HR responses produced by injection of Arg. Peripheral α-adrenergic blockade with phentolamine blocked the hypertension responses to injection of Arg into the LSN. Conclusion: Arg acts in the region of the LSN to exert a central action on the cardiovascular system that is mediated by stimulation of sympathetic outflow.
Original language | English (US) |
---|---|
Pages (from-to) | 49-52 |
Number of pages | 4 |
Journal | Acta Pharmacologica Sinica |
Volume | 17 |
Issue number | 1 |
State | Published - Jan 1996 |
Externally published | Yes |
Keywords
- argipressin
- blood pressure
- heart rate
- septal nuclei
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)